Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling.

Yan A, Joachims ML, Thompson LF, Miller AD, Canoll PD, Bynoe MS.

J Neurosci. 2019 May 29;39(22):4387-4402. doi: 10.1523/JNEUROSCI.1118-18.2019. Epub 2019 Mar 29.

PMID:
30926752
2.

Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade.

Dunn IF, Du Z, Touat M, Sisti MB, Wen PY, Umeton R, Dubuc AM, Ducar M, Canoll PD, Severson E, Elvin JA, Ramkissoon SH, Lin JR, Cabrera L, Acevedo B, Sorger PK, Ligon KL, Santagata S, Reardon DA.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00190. Epub 2018 Nov 27. No abstract available.

3.

Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.

Winawer MR, Griffin NG, Samanamud J, Baugh EH, Rathakrishnan D, Ramalingam S, Zagzag D, Schevon CA, Dugan P, Hegde M, Sheth SA, McKhann GM, Doyle WK, Grant GA, Porter BE, Mikati MA, Muh CR, Malone CD, Bergin AMR, Peters JM, McBrian DK, Pack AM, Akman CI, LaCoursiere CM, Keever KM, Madsen JR, Yang E, Lidov HGW, Shain C, Allen AS, Canoll PD, Crino PB, Poduri AH, Heinzen EL.

Ann Neurol. 2018 Jun;83(6):1133-1146. doi: 10.1002/ana.25243. Epub 2018 May 16.

4.

Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm.

Ding H, Douglass EF Jr, Sonabend AM, Mela A, Bose S, Gonzalez C, Canoll PD, Sims PA, Alvarez MJ, Califano A.

Nat Commun. 2018 Apr 16;9(1):1471. doi: 10.1038/s41467-018-03843-3.

5.

Craniotomy and Survival for Primary Central Nervous System Lymphoma.

Rae AI, Mehta A, Cloney M, Kinslow CJ, Wang TJC, Bhagat G, Canoll PD, Zanazzi GJ, Sisti MB, Sheth SA, Connolly ES, McKhann GM, Bruce JN, Iwamoto FM, Sonabend AM.

Neurosurgery. 2019 Apr 1;84(4):935-944. doi: 10.1093/neuros/nyy096.

PMID:
29660011
6.

Letter: Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.

Massey SC, Johnston SK, Canoll PD, Bruce JN, Bendok BR, Swanson KR.

Neurosurgery. 2018 Jan 1;82(1):E17-E18. doi: 10.1093/neuros/nyx481. No abstract available.

PMID:
29029349
7.

Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system.

Kinslow CJ, Rajpara RS, Wu CC, Bruce SS, Canoll PD, Wang SH, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Wang TJC.

J Neurooncol. 2017 Jun;133(2):409-417. doi: 10.1007/s11060-017-2450-8. Epub 2017 Apr 26.

PMID:
28447278
8.

Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.

Collins-Praino LE, Francis YI, Griffith EY, Wiegman AF, Urbach J, Lawton A, Honig LS, Cortes E, Vonsattel JP, Canoll PD, Goldman JE, Brickman AM.

Acta Neuropathol Commun. 2014 Aug 17;2:83. doi: 10.1186/s40478-014-0083-0.

9.

PI3K and Bcl-2 inhibition primes glioblastoma cells to apoptosis through downregulation of Mcl-1 and Phospho-BAD.

Pareja F, Macleod D, Shu C, Crary JF, Canoll PD, Ross AH, Siegelin MD.

Mol Cancer Res. 2014 Jul;12(7):987-1001. doi: 10.1158/1541-7786.MCR-13-0650. Epub 2014 Apr 22.

10.

Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo.

Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ, Kandel JJ.

BMC Cancer. 2011 Dec 30;11:529. doi: 10.1186/1471-2407-11-529.

11.

Roles of HAUSP-mediated p53 regulation in central nervous system development.

Kon N, Zhong J, Kobayashi Y, Li M, Szabolcs M, Ludwig T, Canoll PD, Gu W.

Cell Death Differ. 2011 Aug;18(8):1366-75. doi: 10.1038/cdd.2011.12. Epub 2011 Feb 25.

12.

Convection-enhanced delivery in the treatment of malignant glioma.

Lopez KA, Waziri AE, Canoll PD, Bruce JN.

Neurol Res. 2006 Jul;28(5):542-8. Review.

PMID:
16808887
13.

Astrocytoma with pilomyxoid features presenting in an adult.

Komotar RJ, Mocco J, Zacharia BE, Wilson DA, Kim PY, Canoll PD, Goodman RR.

Neuropathology. 2006 Feb;26(1):89-93.

PMID:
16521485
14.

Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.

Angelastro JM, Canoll PD, Kuo J, Weicker M, Costa A, Bruce JN, Greene LA.

Oncogene. 2006 Feb 9;25(6):907-16.

PMID:
16170340
15.

Pilomyxoid astrocytoma: a review.

Komotar RJ, Mocco J, Carson BS, Sughrue ME, Zacharia BE, Sisti AC, Canoll PD, Khandji AG, Tihan T, Burger PC, Bruce JN.

MedGenMed. 2004 Dec 9;6(4):42. Review.

16.

Expression of a truncated receptor protein tyrosine phosphatase kappa in the brain of an adult transgenic mouse.

Shen P, Canoll PD, Sap J, Musacchio JM.

Brain Res. 1999 May 1;826(2):157-71.

PMID:
10224293
17.

GGF/neuregulin induces a phenotypic reversion of oligodendrocytes.

Canoll PD, Kraemer R, Teng KK, Marchionni MA, Salzer JL.

Mol Cell Neurosci. 1999 Feb;13(2):79-94.

PMID:
10192767
18.

Neuregulins as potential neuroprotective agents.

Marchionni MA, Grinspan JB, Canoll PD, Mahanthappa NK, Salzer JL, Scherer SS.

Ann N Y Acad Sci. 1997 Oct 15;825:348-65. Review. No abstract available.

PMID:
9370000
19.

GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors.

Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL.

Neuron. 1996 Aug;17(2):229-43.

20.
21.

Neuregulins as potential drugs for neurological disorders.

Marchionni MA, Kirk CJ, Isaacs IJ, Hoban CJ, Mahanthappa NK, Anton ES, Chen C, Wason F, Lawson D, Hamers FP, Canoll PD, Reynolds R, Cannella B, Meun D, Holt WF, Matthew WD, Chen LE, Gispen WH, Raine CS, Salzer JL, Gwynne DI.

Cold Spring Harb Symp Quant Biol. 1996;61:459-72. Review. No abstract available.

PMID:
9246474
22.

Expression of receptor protein tyrosine phosphatase-sigma (RPTP-sigma) in the nervous system of the developing and adult rat.

Wang H, Yan H, Canoll PD, Silvennoinen O, Schlessinger J, Musacchio JM.

J Neurosci Res. 1995 Jun 15;41(3):297-310.

PMID:
7563223
23.

Cloning of neurotrimin defines a new subfamily of differentially expressed neural cell adhesion molecules.

Struyk AF, Canoll PD, Wolfgang MJ, Rosen CL, D'Eustachio P, Salzer JL.

J Neurosci. 1995 Mar;15(3 Pt 2):2141-56.

24.

The expression of a novel receptor-type tyrosine phosphatase suggests a role in morphogenesis and plasticity of the nervous system.

Canoll PD, Barnea G, Levy JB, Sap J, Ehrlich M, Silvennoinen O, Schlessinger J, Musacchio JM.

Brain Res Dev Brain Res. 1993 Oct 15;75(2):293-8.

PMID:
8261619
25.

The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system.

Levy JB, Canoll PD, Silvennoinen O, Barnea G, Morse B, Honegger AM, Huang JT, Cannizzaro LA, Park SH, Druck T, et al.

J Biol Chem. 1993 May 15;268(14):10573-81.

26.

Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases.

Barnea G, Silvennoinen O, Shaanan B, Honegger AM, Canoll PD, D'Eustachio P, Morse B, Levy JB, Laforgia S, Huebner K, et al.

Mol Cell Biol. 1993 Mar;13(3):1497-506.

29.

Autoradiographic localization of [3H]dextromethorphan (DM) in guinea pig brain: allosteric enhancement by ropizine.

Canoll PD, Smith PR, Gottesman S, Musacchio JM.

Prog Clin Biol Res. 1990;328:171-4. No abstract available.

PMID:
2304943
30.

Dextromethorphan sites, sigma receptors, and the psychotomimetic effects of sigma opiates.

Musacchio JM, Klein M, Canoll PD.

Prog Clin Biol Res. 1990;328:13-6. Review.

PMID:
2154766
31.

Autoradiographic localization of [3H]dextromethorphan in guinea pig brain: allosteric enhancement by ropizine.

Canoll PD, Smith PR, Gottesman S, Musacchio JM.

J Neurosci Res. 1989 Oct;24(2):311-28.

PMID:
2585552
32.

Dextromethorphan and sigma ligands: common sites but diverse effects.

Musacchio JM, Klein M, Canoll PD.

Life Sci. 1989;45(19):1721-32. Review.

PMID:
2556614

Supplemental Content

Loading ...
Support Center